Premium
KEY GENETIC AND MOLECULAR ABERRATIONS IDENTIFIED IN BOTH ADULT AND EBV‐POSITIVE BURKITT LYMPHOMA PATIENTS
Author(s) -
Orem J.,
Martin M.R.,
Mbulaiteye S. M.,
Mullighan C. G.,
Mungall A. J.,
Mungall K.,
Namirembe C.,
Noy A.,
Petrello H.,
Ogwang M. D.,
Martin J.P.,
Reynolds S. J.,
Swerdlow S. H.,
TraverseGlehen A.,
Wilson W. H.,
Marra M. A.,
Staudt L. M.,
Scott D. W.,
Morin R. D.,
Timothy G.,
Dryer M.,
Dreval K.,
Gerhard D. S.,
Hilton L. K.,
Abramson J. S.,
Bartlett N. L.,
Bethony J.,
Bowen J.,
Bryan A.,
Casper C.,
Thomas N.,
GastierFoster J. M.,
Grande B. M,
Griner N. B.,
Gross T. G.,
Harris N. L.,
Irvin J. D.,
Jaffe E.,
Leal F.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.68_2879
Subject(s) - somatic hypermutation , lymphoma , cancer research , biology , mutation , epstein–barr virus , population , gene , virus , virology , b cell , medicine , genetics , immunology , antibody , environmental health